Watch World Pneumonia Day Panel Discussion (Nov 2020)

Pneumonia claims the lives of more young children than any other disease – over 800,000 children under 5 each year worldwide are lost to this largely preventable infectious disease. The COVID-19 pandemic now threatens global progress on preventing and treating childhood pneumonia, potentially reversing decades of health gains for the world’s most vulnerable children. A panel discussed featuring leading scientists and child health advocates addressing the urgent need to maintain progress in fighting childhood pneumonia in the COVID-19 era.

Hosted by

Cynthia Gorney

Cynthia Gorney is a National Geographic writer who served for 16 years as a professor at U.C. Berkeley’s Graduate School of Journalism. A former Washington Post national and foreign correspondent, she has also written for many other magazines, including The New Yorker and The New York Times Magazine; and is the author of Articles of Faith: A Frontline History of the Abortion Wars. For a 2017 National Geographic article about crucial delivery and access challenges for children’s pneumococcal conjugate vaccines, she spent weeks in Bangladesh learning from the renowned microbiologist Samir Saha and his colleagues in pneumonia research.


Anuradha Gupta, MBA

Anuradha Gupta is the Deputy Chief Executive Officer of Gavi, the Vaccine Alliance. Since joining Gavi in 2015, Anuradha has led efforts to put equity and gender at the centre of Gavi’s programmatic planning and to tailor support to countries within Gavi’s strategy. She has also driven efforts to create a new model of country-level Alliance support, through the establishment of a Partners’ Engagement Framework. At the same time, Anuradha has helped improve country ownership and leadership of Gavi-supported programmes besides enhancing accountability for results.

Bryan N. Patenaude, ScD

Bryan is an economist at IVAC and an assistant professor of economic evaluation at the Johns Hopkins Bloomberg School of Public Health’s Department of International Health. At IVAC, Bryan is the PI of the fourth iteration of the Decade of Vaccine Economics (DoVE-IV) project. The DoVE project seeks to quantify the economic cost-of-illness associated with vaccine-preventable diseases and quantify the return-on-investment of vaccines, globally. Bryan’s other work focuses on assessing the strength, sustainability, and efficiency of health financing in low and lower-middle income countries, applying behavioral economics to the evaluation of public health policy, designing contracts and incentives for an efficient health workforce, and understanding the medium and long-term causal impact of health investments on non-health sectors.

Keith Klugman, PhD, MD

Professor Keith Klugman is the Director of the Pneumonia, Meningitis, Neonatal Sepsis and Antimicrobial Resistance Programs at the Bill and Melinda Gates Foundation in Seattle WA. He is the Emeritus William H. Foege Chair of Global Health at the Hubert Department of Global Health, Emory University, Atlanta, Georgia. In addition, he serves as an Honorary Professor in the Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, in Johannesburg, South Africa. His work demonstrating pneumococcal conjugate vaccine efficacy in the developing world, has led to interventions that continue to save millions of lives especially in Africa and in Asia.

Samir K Saha, PhD, FRCPath

Prof. Samir K Saha is known globally for his research on pediatric infectious diseases with specific focus on pneumonia, meningitis, and enteric fever in Bangladesh. He strives to find the true burden of these diseases, their causative organisms, drug resistance patterns and serotype distribution. His work facilitated the introduction of the Hib and pneumococcal vaccines in Bangladesh. He was the first scientist from a developing country to receive the American Society for Microbiology award for his outstanding research in Clinical Microbiology. He was also awarded the Carlos J. Finlay UNESCO Prize for Microbiology. Prof. Saha is the of Head of Microbiology Department of Dhaka Shishu (Children’s) Hospital, and the Executive Director of Child Health Research Foundation, Bangladesh

Senjuti Saha, PhD

Senjuti Saha is a scientist at the Child Health Research Foundation in Bangladesh, working at the intersection of clinical microbiology and global health. She focuses on pediatric preventable infectious diseases, with the goals of using state-of-the art technology including on-site metagenomics to identify etiologies that elude standard laboratory testing in LMICs, and understanding the indirect impacts of interventions like vaccines on the overall health system. Her work is grounded in advancing health and research equity. She is a member of the Polio Transition Independent Monitoring Board of the Global Polio Eradication Initiative, a Gates Goalkeeper of SDGs, and an Associate Editor of BMJ Global health.

Temie Giwa- Tubosun

Temie Giwa-Tubosun studied International Public Management from the Middlebury Institute of International Studies. She has over 10 years of health management experience with the Department For International Development (DFID), World Health Organization, UNDP, and the Lagos State Government. In 2014, the BBC listed her as one of the 100 Women changing the world. She was also recognized as an African Innovator by Quartz and the World Economic Forum. She is the Founder and CEO of LifeBank; Africa’s healthcare supply chain engine. The company helps hospitals discover essential medical suppliers and delivers them in the right condition and on time.